(Q88976689)
Statements
Inhibition of SARS-CoV-2 infection (previously 2019-nCoV) by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion (English)
0 references
Linlin Bao
Shuai Xia
Meiqin Liu
Chao Wang
Wei Xu
Qiaoshuai Lan
Siliang Feng
Feifei Qi
Lanying Du
Shuwen Liu
Chuan Qin
Zhengli Shi
Yun Zhu
Shibo Jiang
Lu Lu
12 March 2020
0 references